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inter-individual variations were significantly larger than 
intra-individual variations. Further studies are warranted 
to determine the contributions of human gut microbiota to 
nutritional metabolism, health promotion, and prevention/
development of diseases.
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Introduction
The human intestinal bacterial community is diverse (more 
than 1000 species) and varies between individuals (Turn-
baugh et al. 2009; Lahti et al. 2014). Human gut microbi-
ota is thought to play important roles in association with 
dietary habits and diseases such as obesity (Ley et al. 
2006), inflammatory bowel disease (Walters et al. 2014), 
and cancer (Schwabe and Jobin 2013). Human intestinal 
microbiota has been assessed by using terminal restric-
tion fragment length polymorphism analysis (Nagashima 
et al. 2003); however, identifying each bacterial species is 
difficult, as it requires the sequencing of all corresponding 
fragments in a sample. Recently, the use of next-generation 
sequencing (NGS) led to new findings on specific genera 
and species of human intestinal bacteria (Shokralla et al. 
2012; Quail et al. 2012) with a relatively higher sensitivity 
and accuracy with respect to bacterial identification.
In recent case–control studies, significant differences in 
some intestinal bacteria were found between healthy con-
trols and patients with colorectal cancer (Wang et al. 2012; 
Wu et al. 2013; Ahn et al. 2013). However, consistent find-
ings between studies have not been reported regarding the 
risk of colorectal cancer. The subject-specific microbiota is 
Abstract Relationships between human gut microbiota, 
dietary habits, and health/diseases are the subject of epi-
demiological and clinical studies. However, the tempo-
ral stability and variability of the bacterial community in 
fecal samples remain unclear. In this study, middle-aged 
Japanese male and female volunteers (n = 5 each) with-
out disease were recruited from the Sakura Diet Study. 
Fecal samples and lifestyle information were collected in 
every quarter and at each defecation for 7 continuous days. 
Next-generation sequencing of 16S rDNA and hierarchical 
clustering showed no time trend and intra-individual dif-
ferences in both fecal sample sets. Significant inter-indi-
vidual variations in seasonal and daily fecal sample sets 
were detected for 24 and 23 out of 39 selected dominant 
genera (>0.1 % of the total human gut microbiota; occu-
pation rate >85 %), respectively. Intra- to inter-individual 
variance ratios in 26 and 35 genera were significantly <1.0 
for seasonal and daily stabilities. Seasonal variation in fer-
mented milk consumption might be associated with Bifi-
dobacterium composition, but not with Lactobacillus. For 
most of the dominant genera in the human gut microbiota, 
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thought to be stable for a long period (Rajilić-Stojanović 
et al. 2012; Martínez et al. 2013; Faith et al. 2013), whereas 
the composition of each human intestinal bacterium within 
the microbiota has been demonstrated to change rapidly 
with a diet rich in fermented milk (Veiga et al. 2014) and 
animal-based products (David et al. 2014). Thus, the tem-
poral stability and variance remain unclear, rendering bac-
terial analysis in epidemiological and clinical studies.
Using two sets of seasonal and daily fecal samples from 
middle-aged Japanese male and female volunteers (n = 5 
each) without disease recruited from the Sakura Diet Study, 
seasonal and daily stabilities were analyzed by NGS of 16S 
rDNA and hierarchical clustering. We then examined the 
relative contribution of the inter- and intra-individual vari-
ance to each human intestinal bacterium.
Materials and methods
Study subjects
Fecal samples were collected from 10 middle-aged Japa-
nese subjects (five men and five women) from January 
2013 to March 2014. The subjects were systematically 
recruited (based on age, gender, residence, and non-severe 
diseases such as heart and cerebrovascular diseases, and 
cancer) as volunteers from participants in the Sakura Diet 
Study in Shizuoka, located in central Japan. They had lived 
in the area for at least 1 year. Briefly, we orally explained 
to them the purpose of the study and obtained their signed 
informed consent for participation in this study. Lifestyle 
information, including dietary habits, was collected using 
a scientifically validated questionnaire (Tokudome et al. 
2005). During 1-year interval between the first and the sec-
ond administration of the food frequency questionnaires, 
the following samples were systematically collected each 
season: a 3-day dietary record, blood, urine, saliva, feces, 
and green tea samples as well as blood pressure, height, 
and body weight. The study was approved by the Ethics 
Committee, University of Shizuoka (No. 24-24).
Questionnaires on defecation and collection of fecal 
samples
We asked the subjects to collect fecal samples and fill out 
questionnaires on defecation times in every quarter (four 
times, representing seasonal samples), and at all times of 
defecation on 7 continuous days after the fourth season 
(more than three times in 1 week, considering ones with 
constipation). For both sets of samples, soon after defeca-
tion, each fecal sample was individually suspended by the 
study subjects in 100 mM Tris–HCl (pH 9), 40 mM EDTA, 
4 M guanidine thiocyanate (protein denaturant to inhibit 
bacterial growth), and 0.001 % bromothymol, as previously 
described (Fukuda and Fujita 2014; Shiozaki et al. 2014). 
To clarify inter- and intra-individual variations of human 
gut microbiota, we collected seasonal and daily fecal sam-
ple sets from the same subjects.
The questionnaire on defecation included questions on 
defecation clock time, stool volume, stool shape/consist-
ency, and stool color, along with questions regarding die-
tary intake of fermented milk (i.e., yoghurt and fermented 
milk beverages), antibiotics, other medication, probiotics, 
and prebiotics within 1 week or 1 day before fecal collec-
tion. Stool volume was recorded in terms of the number 
(e.g., 0.5, 1 and 2) of Japanese standard chicken egg size 
“S” (i.e., 46–52 g). Color was selected from the following 
categorical variables; “yellow,” “green ocher,” “brown,” 
“blackish brown,” or “slightly blackish,” and shape/consist-
ency was selected from the following categorical variables: 
“watery,” “muddy,” “soft,” “banana shape,” “hard,” or “very 
hard” (Nakamura and Oku 2002).
DNA extraction from fecal samples
Fecal solids in the suspension were broken down by using 
FastPrep 24 Instrument (MP Biomedicals, Santa Ana, CA, 
USA) with zirconia beads at 5 m/s for 2 min. Bacterial 
DNA extraction from 200 μL of the suspension was per-
formed by using a Magtration System 12GC (Precision 
System Science, Japan), with MagDEA DNA 200 (Preci-
sion System Science) as a reagent for the automatic nucleic 
acid extraction.
NGS analysis of bacterial community structure in feces
In this study, a series of representative bacteria in the human 
gut microbiota was analyzed by previously described NGS 
of 16S rDNA methods (Takahashi et al. 2014) using the 
following primers (for the V3–V4 region of 16S rDNA of 
prokaryotes): forward primer 5′-AATGATACGGCGAC 
CACCGAGATCTACACXXXXXXXXACACTCTTTCCC 
TACACGACGCTCTTCCGATCTCCTACGGGNBGC 
ASCAG-3′, where Xs represent the sample-specific 8-bp 
barcode sequences (CTCTCTAT, TATCCTCT, GTAAGG 
AG, ACTGCATA, AAGGAGTA, CTAAGCCT, CGTCT 
AAT, TCTCTCCG, TCGACTAG, and TTCTAGCT) and 
reverse primer 5′-CAAGCAGAAGACGGCATACGAGAT 
Z Z Z Z Z Z Z Z G T G AC T G G AG T T C AG AC G T G T G 
CTCTTCCGATCTGACTACNVGGGTATCTAATCC-3′, 
where Zs represent the sample-specific 8-bp barcode 
sequences (TCGCCTTA, CTAGTACG, TTCTGCCT, GCT 
CAGGA, AGGAGTCC, CATGCCTA, GTAGAGAG, CAG 
CCTCG, TGCCTCTT, TCCTCTAC, TCATGAGC, and 
CCTGAGAT); the underlined sequences represent the PCR 
primer region (Pro341F and Pro805R). Sequencing was 
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Table 1  Possible confounding variables regarding dietary consumption and defecation conditions for each subject (S1 to 10)a,b
NS not significant
a Seasonal and daily stabilities were defined as stabilities in the human gut microbiota for 1 year (i.e., 4 times representing each season) and 
1 week (i.e., 7 continuous days), respectively
b Information on food intake and defecation and fecal samples were collected on defecation times in every quarter during 1 year, and at all 
defecation times during 1 week. We asked volunteers to provide information about such conditions 1 week and 1 day before their defecation, 
respectively. Thus, regarding daily stability, the data were summarized as the values for 1 week. The results on defecation represent the median 
(upper) and inter-quartile range (bottom) based on the data for each season during 1 year and 1 week (4 and at least 3 times)
c The stool volume was expressed as the number (e.g., 0.5, 1, and 2) of Japanese standard chicken egg size “S” (i.e., 40–52 g). The data repre-
sent the median (upper) and inter-quartile range (bottom) at different times (from 3 to 7 times)
d The numbers indicate the following: 1: watery, 2: muddy, 3: soft, 4: banana shape, 5: hard, or 6: very hard
e The letters represent the following: A: yellow, B: green ocher, C: brown, D: blackish brown, E: slightly blackish, or F: blackish
f Shape/consistency: the number of days with defecation in 1 week
g The number of defecation times in 1 week
h The data represent the median (upper) and inter-quartile range (bottom)
i Cochran’s Q-test
S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 P valuei
Seasonal stability
 Fermented milk (the beverages or yoghurt) (day/week)
  Season_1 0 1 6 7 0 0 0 0 0 6 0.022
  Season_2 0 2 7 7 0 0 3 0 0 6
  Season_3 0 0 6 7 4 0 3 0 1 7
  Season_4 1 0 6 7 5 0 0 0 0 5
 Pro-/prebiotics (day/week)
  Season_1 0 0 0 0 0 0 0 0 0 0 NS
  Season_2 0 0 0 0 0 0 0 0 0 0
  Season_3 0 0 0 0 0 0 0 0 0 0
  Season_4 0 0 0 0 0 0 0 0 0 0
 Antibiotics (day/week)
  Season_1 0 0 0 0 0 0 0 0 0 0 NS
  Season_2 0 0 0 0 0 0 0 0 0 0
  Season_3 0 0 0 0 0 0 0 0 0 0
  Season_4 0 0 0 0 0 0 0 0 0 0
 Defecation
  Volumec 3.0 3.5 2.0 4.0 4.8 1.3 3.5 2.5 2.3 1.0
(2.3–3.0) (3.0–4.0) (1.6–3.5) (3.5–4.5) (3.8–4.9) (1.0–1.9) (2.3–4.0) (2.1–2.9) (2.0–2.9) (0.6–1.0)
  Shaped 3–4 3–4 4–5 3–4 3 4 3–4 3–4 4 2–5
  Colore C D–E C A–B C–D B–E D B–D B–C D–E
Daily stability
 Fermented milk (day/
week)
1 0 6 7 5 0 0 0 0 6
 Pro-/prebiotics (day/
week)
0 0 0 0 0 0 0 0 0 0
 Antibiotics (day/week) 0 0 0 0 0 0 0 0 0 0
 Defecation
  Daysf 4 6 7 6 3 4 6 7 7 7
  Timesg 4 7 7 6 3 4 6 7 12 16
  Intervalh (h) 36 23 23 24 45 46 29 24 13 4
(26–51) (17–23) (21–26) (24–30) (41–49) (38–54) (24–29) (24–24) (2–23) (3–17)
  Volumec 2.3 4.0 2.5 2.5 3.0 1.5 4.0 3.0 1.0 1.5
(2.0–2.6) (3.3–4.0) (1.8–2.5) (2.5–2.5) (2.8–4.0) (0.9–2.1) (3.3–4.4) (3.0–3.5) (0.8–1.0) (1.4–2.0)
  Shaped 3–4 2–5 3–4 4 3–4 4 4–6 1–4 3–4 1–3
  Colore B–C D–E C A B–D B–C D–E A–C C–D B–E
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conducted using a paired-end and modified to 2 × 300-bp 
cycle run on an Illumina MiSeq sequencing system (Illu-
mina, San Diego, CA, USA) and MiSeq Reagent Kit ver-
sion 3 (600 Cycle) chemistry. Paired-end sequencing with 
read lengths of 301 bp was performed. After demultiplex-
ing, a clear overlap in the paired-end reads was observed. 
The method of quality filtering of sequences was as follows: 
only reads that had quality value (QV) scores of ≥20 for 
more than 99 % of the sequence were extracted for further 
analysis.
16S rDNA‑based taxonomic analysis
Bacterial identification from sequences was performed 
using the Metagenome@KIN analysis software (World 
Fusion, Japan) and the TechnoSuruga Lab Microbial Iden-
tification database DB-BA 9.0 (TechnoSuruga Laboratory, 
Japan). Regarding the composition (%) of human intestinal 
bacteria, we focused on genera representing >0.1 % of the 
total human gut microbiota, considering the measurement 
precision, which was approximately >85 % in this study. 
Based on the analysis of a series of 20 pooled standard 
samples (i.e., a mixture of our study samples) measured 
within one run (for 2 days), intra-assay coefficients of vari-
ation were <5.0, <10.0, and <15.0 % for 6, 7, and 9 genera, 
respectively, out of the 22 selected human intestinal bac-
teria (>0.2 % of the total human gut microbiota), except 
for Odoribacter. Inter-assay coefficients of variation based 
on replicate analyses of a total of 60 pooled standard sam-
ples over three runs were <7.0 % (<5.0 % for 13 genera 
out of these), except for Bifidobacterium and Akkermansia. 
For the remaining genera (including Collinsella, 0.1–0.2 % 
of the total human gut microbiota), however, the intra- 
and inter-assay coefficients were >15.0, and 2.3–14.4 %, 
respectively.
Statistical analyses
Considering the measurement precision, in the stabil-
ity analyses, hierarchical clustering for the selected 17 
human intestinal bacterium (>1.0 % of the total human 
gut microbiota) was performed using GeneMaths soft-
ware (Applied Maths, Belgium) to obtain an overview 
of the similarity between 16S rDNA genomic profiles 
in the subjects. For clustering, the similarity between 
the profiles was calculated using Pearson’s correlation 
coefficient (rp), while linkage was calculated using the 
Ward method. Each variation in the profiles was visual-
ized by different lengths of branches (i.e., rp) in the clus-
tering tree for seasonal and daily fecal sample sets. For 
mean values of each human intestinal bacterium over 
four seasons (v_four seasons %), rp (only for >1.0 % of the 
total human gut microbiota, considering rp based on 
hierarchical clustering analysis) and Spearman’s correla-
tion coefficients (rs) are shown with each genus for 1–3 
continuous days (v_1d, v_2d, and v_3d %, in the order). 
However, regarding rp and rs for daily fecal sample set, 
the two mean values of 1–3 and 7 days could not be used 
as independent variables.
Cochran’s Q-test was used to assess changes in fer-
mented milk intake. For the selected 39 human intestinal 
bacteria, the inter- and intra-individual differences from 
each composition of the human intestinal microbiota were 
analyzed by one-way repeated measures ANOVA. Using 
a single imputation method, each mean value was used 
to replace missing values for subjects who could not pro-
vide their fecal samples because of constipation. In case 
of subjects with two or more defecations in a day, mean 
value of all defecations in the day was used. Friedman test, 
as a nonparametric method, was also performed, consid-
ering the small sample size, i.e., 40 seasonal and 72 daily 
fecal samples obtained from the 10 subjects. The total vari-
ance was partitioned by ANOVA into the following two 
sources: (1) inter-individual variance in the subject’s sta-
tionary composition and (2) residual variance, which meas-
ured intra-individual variance in either the seasonal or daily 
fecal sample set (Ogawa et al. 1999). We also calculated 
the number of days needed to estimate the true value with 
95 % confidence intervals within 10 and 20 % of their true 
mean (Beaton et al. 1979). These analyses were performed 




Means [standard deviation (SD)] of age and BMI were 37.2 
(2.5) and 38.2 (10.0) years and 26.4 (3.5) and 23.1 (1.6) kg/
m2 in men and women, respectively. Fermented milk intake 
and defecation conditions of each subject are presented in 
Table 1. Significant seasonal variation was found for fer-
mented milk intake (times/week) (p = 0.022). Probiotics, 
prebiotics, or antibiotics were not used by the recruited 
Fig. 1  Double-hierarchical clustering of the 17 selected dominant 
genera and individual fecal samples collected for each season. As 
reference, the scale for the genus (representing >1.0 % of the total 
human gut microbiota) was attached on the above panel of the fig-
ure because it was not being outputted in the original figure. The gen-
era and distances between them are depicted. On the right and left, 
samples are expressed by combined codes for the 10 subjects (S1–
S10) and four seasons (1–4), and distances between the samples are 
depicted. Using the Ward method, each distance matrix between the 
genera or the samples is shown as Pearson’s correlation coefficient 
(rp)
▸
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volunteers. Regarding daily fecal samples, three subjects 
had constipation and two subjects had frequent defecation. 
The fecal volume, shape/consistency, and color did not 
change over the week.
Inter‑ and intra‑individual variations for each intestinal 
human bacterium
We grouped each 16S rDNA genomic profile by using hier-
archical clustering for the selected 17 genera represent-
ing >1.0 % of the total human gut microbiota (Figs. 1, 2). 
Regarding both seasonal and daily stabilities, no time trend 
was observed for each subject. Even if they were adjacent, 
consistent continuous orders (i.e., “season 1–4” or “day 
1–7”) were not observed. Obviously, rp were greater for 
daily than for seasonal stability. For both sets of samples, 
Prevotella and Bacteroides were classified in the two larg-
est clusters, at the right and left, respectively (Figs. 1 and 
2). Moreover, except Bifidobacterium, most rs between 
v_four seasons and v_2d or v_3d % were similar or greater than 
those between v_four seasons and v_1d % (e.g., rs = 0.38_0.89, 
0.46_0.62, and 0.32_0.53, and 0.64_0.91, 0.78_0.95, and 
0.79_0.95 for v_1d to v_3d % in Bifidobacterium and Bac-
teroides, respectively). Most of rp were similar to the cor-
responding rs, but rp in Bifidobacterium, Prevotella, Meg-
amonas, and Roseburia were apparently greater (data not 
shown).
Means (SD) of each intestinal human bacterium in sea-
sonal and daily fecal sample sets are presented in Tables 2 
and 3. The following 39 genera (>0.1 % of the total human 
gut microbiota) were identified in the human gut micro-
biota: Bifidobacterium, Collinsella, Eggerthella, Alistipes, 
Bacteroides, Barnesiella, Butyricimonas, Odoribacter, 
Parabacteroides, Prevotella, Acetivibrio, Anaerostipes, 
Bacillus, Blautia, Catenibacterium, Clostridium, Coproc-
occus, Dialister, Dorea, Eubacterium, Faecalibacterium, 
Lachnospira, Megamonas, Megasphaera, Mitsuokella, 
Oscillibacter, Phascolarctobacterium, Pseudoflavonifrac-
tor, Roseburia, Ruminococcus, Sporobacter, Streptococcus, 
Subdoligranulum, Veillonella, Brevundimonas, Mesorhizo-
bium, Parasutterella, Sutterella, and Akkermansia in the 
order listed in Tables 2 and 3. Significant inter-individual 
variations (i.e., differences between subjects) were found 
in 15 and 14 out of the selected 17 genera (>1.0 % of the 
total human gut microbiota) and in 9 out of the remaining 
22 (0.1_1.0 % of them). Several genera such as Prevotella 
were not detected in some subjects, and the number of such 
genera was greater in the seasonal fecal sample set. Sea-
sonal variation (differences between seasons), but not daily 
variation (differences between days), was found only for 
composition of Dorea (P < 0.05). Likewise, P values for 
“Subjects” and “Season” or “Day” based on Friedman test 
were almost the same (data not shown). Among the S2, S5, 
and S7 subjects, changes in Bifidobacterium composition 
might correspond with seasonal changes in fermented milk 
consumption (1.5 ± 2.0 and 5.8 ± 7.0 % for non-ingested 
and ingested seasons, respectively, Friedman test P = 0.08).
Relative contributions of intra‑(A) and inter‑individual 
variance (B) in each human intestinal bacterium
Relative contributions of intra-(A) and inter-individual vari-
ance (B) in each genus and the coefficients of within-person 
variance (CVw) and between-person variance (CVb) are pre-
sented in Tables 4 and 5. We also calculated the number of 
days of fecal sample collection required to estimate the true 
composition within 10 and 20 % of their true mean. In sea-
sonal and daily fecal sample sets, A/B ratios for 26 and 35 
out of the 39 selected genera were <1.0, except for Bacillus, 
Megasphaera, Mitsuokella, Sporobacter, Brevundimonas, 
and Mesorhizobium. In the two fecal sample sets, the mean 
values of each genus were similar, except for Prevotella, 
Mitsuokella, and Brevundimonas (1.5 vs. 3.5, 0.1 vs. 0.4, 
and 0.1 vs. 1.1 %, respectively). Compared with CVb, the 
values of CVw were apparently greater for the seasonal fecal 
sample set than for the daily one, and most CVb values were 
>100 % for both fecal sample sets. The former values in 
compositions of Bifidobacterium and Dorea were >2 times 
greater in the seasonal fecal sample set than in the daily one, 
and the latter values in those of 28 genera were >100 % 
in both or either fecal sample set. According to relatively 
greater latter values, it might be difficult to accurately esti-
mate the true means, but significant or greater “differences 
between subjects” (i.e., inter-individual variance) were sup-
ported by the results presented in Tables 2, 3, 4, and 5. 
Discussion
In the seasonal and daily fecal sample sets, 39 genera rep-
resenting >0.1 % of total bacteria were identified in the 
human gut microbiota and occupied approximately >85 % 
of the total human gut microbiota. In the two dendrograms 
for 17 genera that represent >1.0 % of the total human gut 
microbiota, no time trend of fecal sample collection was 
found and intra-individual variations were observed in 
Fig. 2  Double-hierarchical clustering of the 17 selected dominant 
genera and individual fecal samples collected for 7 continuous days. 
As reference, the scale for the genus (representing >1.0 % of the total 
human gut microbiota) was attached on the above panel of the figure 
because it was not being outputted in the original figure. The genera 
and distances between them are depicted. On the right and left, sam-
ples are expressed by combined codes for the 10 subjects (S1–S10) and 
7 days (day 1–7), and distances between the samples are also depicted. 
Using the Ward method, each distance matrix between the genera or 
the samples is shown as Pearson’s correlation coefficient (rp)
◂
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Table 2  Compositions (%) of 39 selected dominant genera in the human gut microbiota of the 10 subjects (S1–S10), based on seasonal stability
Phylum Subject (S1–S10)
Genus S1 S2 S3 S4 S5 S6
Actinobacteria
 Bifidobacterium 4.0 ± 4.2a 8.6 ± 6.9 8.8 ± 3.6 1.6 ± 1.3 2.0 ± 2.8 6.2 ± 5.8
 Collinsella 5.1 ± 1.6 4.7 ± 1.1 0.1 ± 0.1 0.4 ± 0.6 3.8 ± 0.7 3.7 ± 0.2
 Eggerthella 0.1 ± 0.1 0.0 ± 0.0 0.2 ± 0.1 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Bacteroidetes
 Alistipes 1.2 ± 0.5 0.9 ± 0.7 0.5 ± 0.3 2.2 ± 0.5 1.2 ± 0.3 2.4 ± 0.8
 Bacteroides 11.4 ± 1.3 24.0 ± 7.2 25.6 ± 4.6 10.4 ± 4.6 17.5 ± 3.3 9.7 ± 3.5
 Barnesiella 0.4 ± 0.2 – 0.0 ± 0.0 0.8 ± 0.4 – 0.1 ± 0.0
 Butyricimonas 0.1 ± 0.0 0.1 ± 0.1 0.0 ± 0.1 0.1 ± 0.2 0.1 ± 0.1 0.2 ± 0.0
 Odoribacter 0.5 ± 0.5 0.0 ± 0.0 0.1 ± 0.1 0.2 ± 0.1 0.2 ± 0.0 0.3 ± 0.0
 Parabacteroides 0.8 ± 0.2 3.3 ± 3.6 1.8 ± 0.7 2.5 ± 1.1 0.0 ± 0.0 1.5 ± 0.3
 Prevotella 10.2 ± 6.5 0.3 ± 0.3 0.0 ± 0.0 0.3 ± 0.4 0.0 ± 0.0 1.0 ± 1.4
Firmicutes
 Acetivibrio 0.0 ± 0.0 – 0.0 ± 0.0 0.5 ± 0.3 0.0 ± 0.0 0.0 ± 0.0
 Anaerostipes 0.2 ± 0.1 1.6 ± 0.9 3.2 ± 0.5 1.9 ± 1.5 0.1 ± 0.1 1.2 ± 0.1
 Bacillus 0.0 ± 0.0 – 0.0 ± 0.0 0.1 ± 0.1 0.3 ± 0.3 0.0 ± 0.0
 Blautia 9.7 ± 3.5 14.5 ± 1.3 15.2 ± 3.3 14.7 ± 5.1 22.2 ± 3.9 9.8 ± 1.9
 Catenibacterium 0.0 ± 0.0 0.0 ± 0.1 0.0 ± 0.0 1.3 ± 1.6 – 0.0 ± 0.0
 Clostridium 2.4 ± 0.7 3.6 ± 0.4 3.7 ± 1.1 3.6 ± 0.8 1.8 ± 0.9 2.3 ± 0.6
 Coprococcus 2.3 ± 0.5 0.0 ± 0.0 1.3 ± 0.3 1.4 ± 1.6 3.6 ± 0.3 1.6 ± 0.7
 Dialister 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.8 ± 0.3
 Dorea 1.8 ± 0.3 1.5 ± 0.5 1.9 ± 0.3 0.3 ± 0.4 0.0 ± 0.0 1.0 ± 0.3
 Eubacterium 5.7 ± 0.4 2.9 ± 0.5 4.8 ± 1.3 7.4 ± 1.5 5.4 ± 1.1 4.8 ± 0.8
 Faecalibacterium 7.4 ± 2.9 4.7 ± 1.5 2.0 ± 1.2 7.0 ± 1.5 6.7 ± 2.9 5.2 ± 2.2
 Lachnospira 0.0 ± 0.0 1.6 ± 0.9 0.2 ± 0.2 1.0 ± 0.6 0.3 ± 0.2 0.6 ± 0.1
 Megamonas 7.2 ± 6.1 0.0 ± 0.0 0.0 ± 0.0 0.1 ± 0.1 0.0 ± 0.0 0.2 ± 0.2
 Megasphaera 1.7 ± 1.6 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 – 0.7 ± 0.4
 Mitsuokella – 0.4 ± 0.7 – – – 0.6 ± 0.4
 Oscillibacter 0.8 ± 0.4 0.1 ± 0.1 0.2 ± 0.1 1.3 ± 0.5 1.0 ± 0.2 0.6 ± 0.2
 Phascolarctobacterium 1.0 ± 0.4 1.3 ± 0.5 0.1 ± 0.1 0.7 ± 0.4 1.4 ± 0.3 0.0 ± 0.0
 Pseudoflavonifractor 0.2 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 0.2 ± 0.1 0.4 ± 0.0 0.5 ± 0.1
 Roseburia 0.4 ± 0.3 3.7 ± 0.9 0.3 ± 0.4 1.6 ± 0.4 0.7 ± 0.7 1.0 ± 0.4
 Ruminococcus 7.1 ± 1.1 6.5 ± 1.9 3.2 ± 1.7 7.7 ± 0.4 9.2 ± 3.0 10.1 ± 0.7
 Sporobacter 0.1 ± 0.1 0.0 ± 0.0 0.0 ± 0.0 0.2 ± 0.0 0.2 ± 0.1 0.4 ± 0.1
 Streptococcus 1.3 ± 0.8 1.8 ± 1.1 10.4 ± 2.6 2.0 ± 1.3 0.7 ± 0.5 0.3 ± 0.2
 Subdoligranulum 2.8 ± 1.1 2.1 ± 1.0 3.3 ± 1.8 1.0 ± 1.6 10.0 ± 1.8 2.2 ± 0.6
 Veillonella 0.1 ± 0.1 0.2 ± 0.3 4.5 ± 1.8 0.1 ± 0.2 0.0 ± 0.0 0.0 ± 0.0
Proteobacteria
 Brevundimonas 0.1 ± 0.1 0.1 ± 0.1 0.0 ± 0.0 0.2 ± 0.4 0.0 ± 0.0 0.1 ± 0.1
 Mesorhizobium 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.1 ± 0.1 – 0.0 ± 0.0
 Parasutterella 0.0 ± 0.0 1.5 ± 0.5 0.0 ± 0.0 0.1 ± 0.1 0.5 ± 0.1 0.4 ± 0.1
 Sutterella 1.0 ± 0.2 0.0 ± 0.0 0.0 ± 0.0 0.1 ± 0.3 0.8 ± 0.2 0.0 ± 0.0
Verrucomicrobia
 Akkermansia 0.0 ± 0.1 0.0 ± 0.0 0.1 ± 0.2 1.1 ± 0.5 0.0 ± 0.0 0.3 ± 0.4
Others 12.9 ± 2.9 9.7 ± 0.5 8.2 ± 1.2 25.7 ± 3.8 9.8 ± 2.4 30.2 ± 4.0
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Table 2  continued
Phylum Subject (S1–S10) P valueb
Genus S7 S8 S9 S10 Subject Season
Actinobacteria
 Bifidobacterium 0.3 ± 0.5 4.5 ± 4.7 4.1 ± 3.2 6.2 ± 4.5 0.001 0.740
 Collinsella 1.5 ± 0.9 3.5 ± 1.3 1.5 ± 0.3 2.8 ± 1.1 0.001 0.077
 Eggerthella 0.3 ± 0.1 0.1 ± 0.1 –c 0.1 ± 0.0 0.013 0.935
Bacteroidetes
 Alistipes 0.0 ± 0.0 0.0 ± 0.0 0.2 ± 0.1 0.7 ± 0.4 0.007 0.513
 Bacteroides 34.3 ± 3.6 20.0 ± 5.7 1.2 ± 0.7 22.5 ± 4.7 <0.001 0.204
 Barnesiella – – 0.0 ± 0.0 0.0 ± 0.0 0.152 0.226
 Butyricimonas 0.2 ± 0.1 0.0 ± 0.0 0.3 ± 0.1 0.0 ± 0.0 0.006 0.378
 Odoribacter 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.1 0.2 ± 0.1 0.015 0.514
 Parabacteroides 0.1 ± 0.0 1.6 ± 0.8 1.1 ± 0.4 1.6 ± 1.6 0.002 0.462
 Prevotella 0.0 ± 0.0 0.0 ± 0.0 2.6 ± 2.0 0.1 ± 0.1 0.183 0.196
Firmicutes
 Acetivibrio 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 – 0.274 0.400
 Anaerostipes 7.9 ± 0.6 0.1 ± 0.1 0.3 ± 0.3 4.6 ± 1.1 0.026 0.715
 Bacillus 0.3 ± 0.3 0.1 ± 0.2 0.2 ± 0.2 0.0 ± 0.1 0.019 0.443
 Blautia 21.3 ± 1.4 17.2 ± 7.1 8.8 ± 3.2 14.7 ± 1.6 <0.001 0.382
 Catenibacterium 0.0 ± 0.0 0.0 ± 0.0 4.9 ± 2.4 0.0 ± 0.0 0.237 0.541
 Clostridium 3.7 ± 0.6 3.7 ± 2.7 2.9 ± 0.8 3.1 ± 0.6 <0.001 0.404
 Coprococcus 1.2 ± 0.1 0.0 ± 0.0 1.7 ± 0.6 0.6 ± 0.1 0.003 0.547
 Dialister 0.0 ± 0.0 1.3 ± 0.7 0.7 ± 0.4 0.0 ± 0.0 0.084 0.445
 Dorea 3.0 ± 0.8 2.3 ± 1.0 0.8 ± 0.2 1.5 ± 0.4 0.001 0.016
 Eubacterium 1.8 ± 0.8 1.8 ± 1.0 5.3 ± 1.0 8.2 ± 2.6 <0.001 0.129
 Faecalibacterium 7.8 ± 3.7 1.0 ± 0.7 3.7 ± 1.7 7.5 ± 0.7 <0.001 0.504
 Lachnospira 0.0 ± 0.0 1.0 ± 0.7 0.3 ± 0.2 0.2 ± 0.1 0.011 0.726
 Megamonas 0.2 ± 0.3 20.3 ± 8.8 0.1 ± 0.1 0.1 ± 0.1 0.206 0.353
 Megasphaera 0.0 ± 0.1 4.3 ± 3.9 0.0 ± 0.0 0.0 ± 0.0 0.156 0.387
 Mitsuokella – 0.0 ± 0.0 0.1 ± 0.1 – 0.119 0.469
 Oscillibacter 0.0 ± 0.0 0.1 ± 0.0 1.3 ± 0.3 0.3 ± 0.2 0.006 0.599
 Phascolarctobacterium 2.2 ± 0.4 0.0 ± 0.0 1.5 ± 0.3 1.1 ± 0.2 0.003 0.996
 Pseudoflavonifractor 0.0 ± 0.0 0.2 ± 0.2 0.3 ± 0.1 0.1 ± 0.1 0.003 0.243
 Roseburia 0.4 ± 0.2 0.2 ± 0.2 0.8 ± 0.7 0.8 ± 0.3 0.015 0.266
 Ruminococcus 8.1 ± 1.0 1.6 ± 1.0 7.3 ± 2.7 10.5 ± 0.9 <0.001 0.203
 Sporobacter – 0.0 ± 0.0 1.0 ± 0.5 0.0 ± 0.0 0.096 0.253
 Streptococcus 1.0 ± 0.3 6.4 ± 3.2 0.5 ± 0.4 0.7 ± 0.4 0.040 0.448
 Subdoligranulum 0.1 ± 0.1 0.6 ± 0.5 6.6 ± 1.5 2.1 ± 0.7 0.011 0.672
 Veillonella 0.1 ± 0.0 0.1 ± 0.1 0.0 ± 0.0 0.0 ± 0.0 0.270 0.379
Proteobacteria
 Brevundimonas 0.0 ± 0.0 0.0 ± 0.0 0.9 ± 1.2 0.1 ± 0.0 0.109 0.409
 Mesorhizobium 0.0 ± 0.0 0.0 ± 0.0 0.1 ± 0.1 0.0 ± 0.0 0.173 0.683
 Parasutterella 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.136 0.383
 Sutterella 0.0 ± 0.0 0.0 ± 0.0 0.1 ± 0.1 1.4 ± 0.2 0.065 0.090
Verrucomicrobia
 Akkermansia 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 1.1 ± 1.0 0.090 0.583
Others 4.0 ± 0.4 7.9 ± 3.5 38.9 ± 7.9 6.9 ± 1.7 0.003 0.215
a The individual mean ± SD was calculated using all values for 1 year
b According to one-way repeated measures ANOVA, the residual was defined as “Season.” The two variables, “Subject” and “Season,” corre-
spond to “inter-” and “intra-” individual variations, respectively
c Not detected
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Table 3  Compositions (%) of 39 selected dominant genera in the human gut microbiota for the 10 subjects (S1–S10), based on daily stability
Phylum Subject (S1–S10)
Genus S1 S2 S3 S4 S5 S6
Actinobacteria
 Bifidobacterium 4.0 ± 4.2a 8.6 ± 6.9 8.8 ± 3.6 1.6 ± 1.3 2.0 ± 2.8 6.2 ± 5.8
 Collinsella 5.1 ± 1.6 4.7 ± 1.1 0.1 ± 0.1 0.4 ± 0.6 3.8 ± 0.7 3.7 ± 0.2
 Eggerthella 0.1 ± 0.1 0.0 ± 0.0 0.2 ± 0.1 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Bacteroidetes
 Alistipes 1.2 ± 0.5 0.9 ± 0.7 0.5 ± 0.3 2.2 ± 0.5 1.2 ± 0.3 2.4 ± 0.8
 Bacteroides 11.4 ± 1.3 24.0 ± 7.2 25.6 ± 4.6 10.4 ± 4.6 17.5 ± 3.3 9.7 ± 3.5
 Barnesiella 0.4 ± 0.2 – 0.0 ± 0.0 0.8 ± 0.4 – 0.1 ± 0.0
 Butyricimonas 0.1 ± 0.0 0.1 ± 0.1 0.0 ± 0.1 0.1 ± 0.2 0.1 ± 0.1 0.2 ± 0.0
 Odoribacter 0.5 ± 0.5 0.0 ± 0.0 0.1 ± 0.1 0.2 ± 0.1 0.2 ± 0.0 0.3 ± 0.0
 Parabacteroides 0.8 ± 0.2 3.3 ± 3.6 1.8 ± 0.7 2.5 ± 1.1 0.0 ± 0.0 1.5 ± 0.3
 Prevotella 10.2 ± 6.5 0.3 ± 0.3 0.0 ± 0.0 0.3 ± 0.4 0.0 ± 0.0 1.0 ± 1.4
Firmicutes
 Acetivibrio 0.0 ± 0.0 – 0.0 ± 0.0 0.5 ± 0.3 0.0 ± 0.0 0.0 ± 0.0
 Anaerostipes 0.2 ± 0.1 1.6 ± 0.9 3.2 ± 0.5 1.9 ± 1.5 0.1 ± 0.1 1.2 ± 0.1
 Bacillus 0.0 ± 0.0 – 0.0 ± 0.0 0.1 ± 0.1 0.3 ± 0.3 0.0 ± 0.0
 Blautia 9.7 ± 3.5 14.5 ± 1.3 15.2 ± 3.3 14.7 ± 5.1 22.2 ± 3.9 9.8 ± 1.9
 Catenibacterium 0.0 ± 0.0 0.0 ± 0.1 0.0 ± 0.0 1.3 ± 1.6 – 0.0 ± 0.0
 Clostridium 2.4 ± 0.7 3.6 ± 0.4 3.7 ± 1.1 3.6 ± 0.8 1.8 ± 0.9 2.3 ± 0.6
 Coprococcus 2.3 ± 0.5 0.0 ± 0.0 1.3 ± 0.3 1.4 ± 1.6 3.6 ± 0.3 1.6 ± 0.7
 Dialister 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.8 ± 0.3
 Dorea 1.8 ± 0.3 1.5 ± 0.5 1.9 ± 0.3 0.3 ± 0.4 0.0 ± 0.0 1.0 ± 0.3
 Eubacterium 5.7 ± 0.4 2.9 ± 0.5 4.8 ± 1.3 7.4 ± 1.5 5.4 ± 1.1 4.8 ± 0.8
 Faecalibacterium 7.4 ± 2.9 4.7 ± 1.5 2.0 ± 1.2 7.0 ± 1.5 6.7 ± 2.9 5.2 ± 2.2
 Lachnospira 0.0 ± 0.0 1.6 ± 0.9 0.2 ± 0.2 1.0 ± 0.6 0.3 ± 0.2 0.6 ± 0.1
 Megamonas 7.2 ± 6.1 0.0 ± 0.0 0.0 ± 0.0 0.1 ± 0.1 0.0 ± 0.0 0.2 ± 0.2
 Megasphaera 1.7 ± 1.6 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 – 0.7 ± 0.4
 Mitsuokella – 0.4 ± 0.7 – – – 0.6 ± 0.4
 Oscillibacter 0.8 ± 0.4 0.1 ± 0.1 0.2 ± 0.1 1.3 ± 0.5 1.0 ± 0.2 0.6 ± 0.2
 Phascolarctobacterium 1.0 ± 0.4 1.3 ± 0.5 0.1 ± 0.1 0.7 ± 0.4 1.4 ± 0.3 0.0 ± 0.0
 Pseudoflavonifractor 0.2 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 0.2 ± 0.1 0.4 ± 0.0 0.5 ± 0.1
 Roseburia 0.4 ± 0.3 3.7 ± 0.9 0.3 ± 0.4 1.6 ± 0.4 0.7 ± 0.7 1.0 ± 0.4
 Ruminococcus 7.1 ± 1.1 6.5 ± 1.9 3.2 ± 1.7 7.7 ± 0.4 9.2 ± 3.0 10.1 ± 0.7
 Sporobacter 0.1 ± 0.1 0.0 ± 0.0 0.0 ± 0.0 0.2 ± 0.0 0.2 ± 0.1 0.4 ± 0.1
 Streptococcus 1.3 ± 0.8 1.8 ± 1.1 10.4 ± 2.6 2.0 ± 1.3 0.7 ± 0.5 0.3 ± 0.2
 Subdoligranulum 2.8 ± 1.1 2.1 ± 1.0 3.3 ± 1.8 1.0 ± 1.6 10.0 ± 1.8 2.2 ± 0.6
 Veillonella 0.1 ± 0.1 0.2 ± 0.3 4.5 ± 1.8 0.1 ± 0.2 0.0 ± 0.0 0.0 ± 0.0
Proteobacteria
 Brevundimonas 0.1 ± 0.1 0.1 ± 0.1 0.0 ± 0.0 0.2 ± 0.4 0.0 ± 0.0 0.1 ± 0.1
 Mesorhizobium 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.1 ± 0.1 – 0.0 ± 0.0
 Parasutterella 0.0 ± 0.0 1.5 ± 0.5 0.0 ± 0.0 0.1 ± 0.1 0.5 ± 0.1 0.4 ± 0.1
 Sutterella 1.0 ± 0.2 0.0 ± 0.0 0.0 ± 0.0 0.1 ± 0.3 0.8 ± 0.2 0.0 ± 0.0
Verrucomicrobia
 Akkermansia 0.0 ± 0.1 0.0 ± 0.0 0.1 ± 0.2 1.1 ± 0.5 0.0 ± 0.0 0.3 ± 0.4
Others 12.9 ± 2.9 9.7 ± 0.5 8.2 ± 1.2 25.7 ± 3.8 9.8 ± 2.4 30.2 ± 4.0
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Table 3  continued
Phylum Subject (S1–S10) P valueb
Genus S7 S8 S9 S10 Subject Day
Actinobacteria
 Bifidobacterium 0.1 ± 0.1 3.4 ± 1.2 4.6 ± 2.7 5.0 ± 1.0 0.002 0.397
 Collinsella 1.1 ± 0.3 5.0 ± 1.9 3.4 ± 1.4 3.2 ± 0.7 0.003 0.749
 Eggerthella 0.3 ± 0.1 0.3 ± 0.2 –c 0.1 ± 0.0 0.008 0.226
Bacteroidetes
 Alistipes 0.1 ± 0.1 0.4 ± 0.9 0.1 ± 0.1 0.8 ± 0.4 0.010 0.752
 Bacteroides 27.9 ± 4.7 20.1 ± 2.5 0.6 ± 0.3 14.6 ± 1.9 <0.001 0.552
 Barnesiella 0.0 ± 0.0 0.1 ± 0.1 0.0 ± 0.0 0.0 ± 0.0 0.125 0.786
 Butyricimonas 0.4 ± 0.1 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.343 0.435
 Odoribacter 0.0 ± 0.0 0.1 ± 0.1 0.0 ± 0.0 0.2 ± 0.1 0.013 0.715
 Parabacteroides 0.0 ± 0.0 1.7 ± 0.6 0.4 ± 0.2 1.2 ± 0.7 0.005 0.227
 Prevotella 0.5 ± 0.2 0.1 ± 0.1 15.9 ± 10.9 0.1 ± 0.1 0.122 0.388
Firmicutes
 Acetivibrio – 0.1 ± 0.2 0.0 ± 0.0 0.0 ± 0.0 0.305 0.254
 Anaerostipes 6.4 ± 0.8 0.3 ± 0.4 0.4 ± 0.1 4.3 ± 0.8 0.010 0.552
 Bacillus 0.0 ± 0.0 0.0 ± 0.0 0.1 ± 0.1 0.0 ± 0.0 0.040 0.612
 Blautia 18.9 ± 2.8 16.7 ± 5.8 7.5 ± 2.1 16.1 ± 1.2 <0.001 0.353
 Catenibacterium 0.0 ± 0.0 0.1 ± 0.1 2.4 ± 0.8 0.0 ± 0.0 0.265 0.447
 Clostridium 5.7 ± 0.8 2.3 ± 0.4 2.0 ± 0.5 3.4 ± 0.5 <0.001 0.592
 Coprococcus 1.0 ± 0.2 0.7 ± 1.4 2.0 ± 0.5 0.7 ± 0.1 0.001 0.312
 Dialister 0.1 ± 0.0 1.0 ± 0.5 2.1 ± 0.4 0.0 ± 0.0 0.094 0.815
 Dorea 2.5 ± 0.4 2.5 ± 0.4 1.0 ± 0.1 1.0 ± 0.1 0.001 0.616
 Eubacterium 2.6 ± 1.0 3.0 ± 1.3 4.7 ± 1.2 6.5 ± 0.6 <0.001 0.625
 Faecalibacterium 12.8 ± 3.6 5.1 ± 2.1 6.6 ± 1.6 10.8 ± 1.2 <0.001 0.683
 Lachnospira 0.1 ± 0.0 0.7 ± 0.4 0.3 ± 0.3 0.3 ± 0.1 0.034 0.380
 Megamonas 0.1 ± 0.1 11.2 ± 7.9 1.6 ± 1.6 0.0 ± 0.1 0.147 0.772
 Megasphaera 0.0 ± 0.0 4.2 ± 3.4 0.0 ± 0.0 0.0 ± 0.0 0.142 0.583
 Mitsuokella – 0.0 ± 0.0 2.5 ± 2.4 0.0 ± 0.0 0.216 0.433
 Oscillibacter 0.0 ± 0.0 0.3 ± 0.4 1.0 ± 0.7 0.4 ± 0.1 0.024 0.608
 Phascolarctobacte-
rium
1.8 ± 0.5 0.2 ± 0.3 0.4 ± 0.2 0.8 ± 0.2 0.006 0.221
 Pseudoflavonifractor 0.0 ± 0.0 0.4 ± 0.2 0.2 ± 0.1 0.1 ± 0.0 0.006 0.761
 Roseburia 0.7 ± 0.2 1.5 ± 0.8 1.1 ± 0.6 0.8 ± 0.4 0.011 0.173
 Ruminococcus 9.8 ± 2.0 3.4 ± 1.4 4.7 ± 0.9 9.7 ± 1.8 <0.001 0.331
 Sporobacter 0.0 ± 0.0 0.0 ± 0.0 0.6 ± 0.5 0.0 ± 0.0 0.073 0.613
 Streptococcus 0.6 ± 0.2 2.2 ± 1.2 0.5 ± 0.1 0.6 ± 0.3 0.087 0.334
 Subdoligranulum 0.2 ± 0.1 2.1 ± 1.1 5.8 ± 3.1 2.5 ± 0.6 0.010 0.618
 Veillonella 0.0 ± 0.0 0.1 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.319 0.454
Proteobacteria
 Brevundimonas 0.2 ± 0.2 1.0 ± 0.9 1.9 ± 2.6 4.7 ± 4.5 0.077 0.173
 Mesorhizobium 0.1 ± 0.1 0.3 ± 0.3 0.2 ± 0.1 0.3 ± 0.2 0.006 0.230
 Parasutterella – 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.164 0.456
 Sutterella 0.0 ± 0.0 0.1 ± 0.2 0.2 ± 0.1 1.3 ± 0.4 0.073 0.127
Verrucomicrobia
 Akkermansia 0.0 ± 0.0 0.2 ± 0.6 0.1 ± 0.1 0.6 ± 0.6 0.268 0.433
Others 5.8 ± 1.0 9.2 ± 8.3 25.3 ± 10.9 9.4 ± 1.5 0.001 0.601
a The individual mean ± SD was calculated using all values for 1 week
b In one-way repeated measures ANOVA, the residual was defined as “Day.” The two variables “Subject” and “Day” correspond to “inter-” and 
“intra-” individual variations, respectively
c Not detected
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Table 4  Relative contributions of intra- and inter-individual variance 
in 39 selected dominant genera, coefficient of within-person variance 
(CVw) and between-person variance (CVb), and the number of days 
(“Days”) of fecal sample collection required to estimate the true val-
ues within 10 and 20 % of their true mean, based on seasonal stability
a The inter-individual (A) variation represents variation between individual subjects, and intra-individual (B) variation represents variation in 
season and residual
b The mean of the composition (%) among the 10 subjects (all 40 samples)
c The number of days of fecal sample collection required to estimate the values within 10 and 20 % of their true mean with 95 % confidence
Phylum Percentage contributions of variance componentsa A/B Meanb CVw CVb Days
c
Genus Intra-individual (A) Inter-individual (B) (%) (%) (%) 10 % 20 %
Actinobacteria
 Bifidobacterium 90.8 9.2 9.8 4.6 94.6 107.5 344 86
 Collinsella 28.5 71.5 0.4 2.7 52.6 70.7 106 27
 Eggerthella 36.9 63.1 0.6 0.1 58.4 106.5 131 33
Bacteroidetes
 Alistipes 28.7 71.3 0.4 0.9 60.2 97.5 139 35
 Bacteroides 22.2 77.8 0.3 17.7 27.9 57.2 30 7
 Barnesiella 29.1 70.9 0.4 0.1 101.5 215.5 395 99
 Butyricimonas 48.0 52.0 0.9 0.1 95.3 102.7 349 87
 Odoribacter 65.1 34.9 1.9 0.2 88.4 137.5 300 75
 Parabacteroides 84.5 15.5 5.4 1.4 66.7 116.3 171 43
 Prevotella 43.0 57.0 0.8 1.5 95.1 257.4 347 87
Firmicutes
 Acetivibrio 46.6 53.4 0.9 0.1 112.6 293.6 487 122
 Anaerostipes 9.8 90.2 0.1 2.1 42.9 117.3 71 18
 Bacillus 91.3 8.7 10.5 0.1 125.7 182.5 607 152
 Blautia 51.9 48.1 1.1 14.8 23.3 38.4 21 5
 Catenibacterium 34.1 65.9 0.5 0.6 136.4 276.1 714 179
 Clostridium 94.7 5.3 17.8 3.1 30.1 41.9 35 9
 Coprococcus 34.3 65.7 0.5 1.4 42.7 86.4 70 18
 Dialister 36.6 63.4 0.6 0.3 104.7 181.2 421 105
 Dorea 31.4 68.6 0.5 1.4 51.5 71.1 102 25
 Eubacterium 33.7 66.3 0.5 4.8 25.5 49.2 25 6
 Faecalibacterium 57.4 42.6 1.3 5.3 41.6 59.5 67 17
 Lachnospira 54.2 45.8 1.2 0.5 60.9 122.5 142 36
 Megamonas 28.3 71.7 0.4 2.8 104.5 250.9 419 105
 Megasphaera 65.3 34.7 1.9 0.7 105.5 276.3 427 107
 Mitsuokella 79.9 20.1 4.0 0.1 118.3 288.6 538 134
 Oscillibacter 28.3 71.7 0.4 0.6 52.6 94.3 106 27
 Phascolarctobacterium 21.5 78.5 0.3 0.9 55.9 80.2 120 30
 Pseudoflavonifractor 39.2 60.8 0.6 0.2 52.4 82.2 105 26
 Roseburia 24.2 75.8 0.3 1.0 67.7 110.9 176 44
 Ruminococcus 34.0 66.0 0.5 7.1 26.4 44.3 27 7
 Sporobacter 34.1 65.9 0.5 0.2 88.5 184.2 301 75
 Streptococcus 21.5 78.5 0.3 2.5 55.2 137.8 117 29
 Subdoligranulum 18.1 81.9 0.2 3.1 53.5 101.3 110 28
 Veillonella 18.9 81.1 0.2 0.5 89.3 274.3 306 77
Proteobacteria
 Brevundimonas 94.5 5.5 17.0 0.1 97.1 310.3 363 91
 Mesorhizobium 92.7 7.3 12.8 0.0 110.6 261.4 470 117
 Parasutterella 17.0 83.0 0.2 0.2 92.8 190.3 331 83
 Sutterella 9.4 90.6 0.1 0.3 99.7 147.6 382 95
Verrucomicrobia
 Akkermansia 58.8 41.2 1.4 0.3 127.7 214.3 626 157
Others 10.8 89.2 0.1 15.4 19.6 76.2 15 4
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Table 5  Relative contributions of intra- and inter-individual variance 
in 39 selected dominant genera, coefficient of within-person variance 
(CVw) and between-person variance (CVb), and the number of days 
(“Days”) of fecal sample collection required to estimate the true val-
ues within 10 and 20 % of their true mean, based on daily stability
a The inter-individual (A) variation represents variation between individual subjects, and intra-individual (B) variation represents day and resid-
ual variations
b Composition mean (%) among the 10 subjects (all 72 samples)
c The number of days of fecal sample collection required to estimate the intake values within 10 and 20 % of their true mean with 95 % confidence
Phylum Percentage contributions of variance componentsa A/B Meanb CVw CVb Days
c
Genus Intra-individual (A) Inter-individual (B) (%) (%) (%) 10 % 20 %
Actinobacteria
 Bifidobacterium 29.8 70.2 0.4 4.2 38.9 85.1 58 15
 Collinsella 18.1 81.9 0.2 3.0 36.1 75.6 50 13
 Eggerthella 41.6 58.4 0.7 0.1 40.0 103.8 61 15
Bacteroidetes
 Alistipes 27.2 72.8 0.4 0.7 74.7 125.8 214 54
 Bacteroides 18.0 82.0 0.2 13.9 29.1 62.5 33 8
 Barnesiella 15.6 84.4 0.2 0.1 142.3 208.5 778 195
 Butyricimonas 11.0 89.0 0.1 0.0 115.3 290.1 511 128
 Odoribacter 29.3 70.7 0.4 0.1 95.9 120.2 353 88
 Parabacteroides 29.5 70.5 0.4 1.1 56.8 92.2 124 31
 Prevotella 27.8 72.2 0.4 3.5 72.5 218.8 202 50
Firmicutes
 Acetivibrio 3.8 96.2 0.0 0.2 128.7 271.4 637 159
 Anaerostipes 17.9 82.1 0.2 2.6 38.0 94.3 56 14
 Bacillus 59.4 40.6 1.5 0.0 130.5 210.1 654 164
 Blautia 24.2 75.8 0.3 14.9 19.5 37.0 15 4
 Catenibacterium 12.2 87.8 0.1 0.3 154.2 241.4 913 228
 Clostridium 20.2 79.8 0.3 3.7 18.8 48.3 14 3
 Coprococcus 34.3 65.7 0.5 1.0 44.7 84.5 77 19
 Dialister 11.7 88.3 0.1 0.5 105.5 164.4 428 107
 Dorea 8.2 91.8 0.1 1.4 28.2 61.5 31 8
 Eubacterium 42.0 58.0 0.7 4.6 27.6 40.2 29 7
 Faecalibacterium 38.0 62.0 0.6 7.0 34.0 51.6 44 11
 Lachnospira 13.8 86.2 0.2 0.7 58.8 132.5 133 33
 Megamonas 27.4 72.6 0.4 2.7 101.3 229.7 394 99
 Megasphaera 43.1 56.9 0.8 0.8 108.4 256.6 451 113
 Mitsuokella 56.6 43.4 1.3 0.4 162.7 324.3 1017 254
 Oscillibacter 23.3 76.7 0.3 0.6 59.3 131.8 135 34
 Phascolarctobacterium 15.2 84.8 0.2 0.6 55.2 92.7 117 29
 Pseudoflavonifractor 26.7 73.3 0.4 0.2 52.3 98.8 105 26
 Roseburia 16.4 83.6 0.2 1.6 54.9 101.8 116 29
 Ruminococcus 24.6 75.4 0.3 6.9 21.6 41.6 18 4
 Sporobacter 47.2 52.8 0.9 0.1 98.3 213.1 371 93
 Streptococcus 28.3 71.7 0.4 2.6 46.5 180.5 83 21
 Subdoligranulum 15.0 85.0 0.2 2.7 32.6 98.3 41 10
 Veillonella 16.9 83.1 0.2 0.5 74.1 275.4 211 53
Proteobacteria
 Brevundimonas 66.5 33.5 2.0 1.1 82.2 213.1 259 65
 Mesorhizobium 70.7 29.3 2.4 0.2 76.6 119.1 226 56
 Parasutterella 2.4 97.6 0.0 0.2 106.1 221.9 433 108
 Sutterella 10.4 89.6 0.1 0.3 96.6 167.7 358 90
Verrucomicrobia
 Akkermansia 23.5 76.5 0.3 0.6 122.2 391.1 574 143
Others 21.7 78.3 0.3 14.3 25.5 73.0 25 6
932 Arch Microbiol (2015) 197:919–934
1 3
seasonal and daily stabilities. However, compared with the 
intra-individual variation, a greater inter-individual varia-
tion was found to be statistically significant for almost all 
39 selected dominant genera. This suggest that “differences 
between subjects” were detected based on their human 
gut bacterial community structure. Our data indicated that 
changes in the gut human microbiota composition in term 
of Bifidobacterium, but not Lactobacillus, corresponded to 
seasonal variations in fermented milk consumption.
Dietary assessment studies indicated that inter-individ-
ual variance was smaller than intra-individual variance in 
term of dietary intake of foods and nutrients (Ogawa et al. 
1999; Tokudome et al. 2002). Similarly, among American-
European individuals, A/B ratios have been reported to be 
smaller for dietary intake of macronutrients such as pro-
tein and carbohydrates, but not for that of minerals and 
vitamins. In our study, A/B ratios were also smaller for 
the 39 selected dominant genera, excluding few of them. 
Thus, similar to dietary assessments, bacterial commu-
nity structure in the human gut allows the assessment of 
the intestinal microbiota composition for such dominant 
selected genera (and species; see supplemental Tables S1 
to S4). However, the number of days of dietary information 
or fecal sample collection for both assessment of dietary 
foods/nutrient intake and bacterial community structure 
were not small to estimate the true values within 10 and 
20 % of their true means. Even if rs were adequately higher 
for some of the human intestinal bacteria, it might be dif-
ficult to precisely estimate point values for an individual 
subject, but not mean values in a group of subjects, because 
of CVw greater values. This study was performed by using 
bacterial genus data to assess seasonal and daily stabilities 
of the human intestinal bacteria, but further investigation 
is needed to determine the relationships between bacterial 
species data, dietary habits, and health/diseases.
Large-scale projects such as the Human Microbiome 
Project and Meta-HIT have made substantial progress 
toward understanding the symbiotic relationships between 
the human gut microbiota and their hosts (The Human 
Microbiome Project Consortium 2012; Qin et al. 2012). 
According to cross-national cluster analyses, three ente-
rotypes have been identified; i.e., Bacteroides, Prevotella, 
and Ruminococcus (Arumugam et al. 2011). Bacteroides 
and Prevotella compositions have been reported to be 
associated with host meals rich in animal proteins, several 
amino acids, and saturated fats as well as host diet featur-
ing carbohydrates and monosaccharide (Wu et al. 2011; 
David et al. 2014). Moreover, higher consumption of fer-
mented milk or administration of probiotics and prebiotics 
has been demonstrated to increase Bifidobacterium com-
position (Saito et al. 2002; Matsumoto et al. 2010; Petry 
et al. 2012). This study also found that changes in Bifido-
bacterium composition might correspond with seasonal 
changes in terms of fermented milk consumption, and this 
is related to greater values of intra-individual variation and 
greater A/B ratios for Bifidobacterium. However, further 
studies are needed to clarify the association between fer-
mented milk intake and the proportions of Bifidobacterium 
and Lactobacillus in the microbiota for each season. In epi-
demiological studies, therefore, the composition of human 
intestinal bacteria has been shown to associate with change 
based on food ingestion or administration of supplements.
Individually, unique compositions of human intestinal 
bacterium were shown in 24 fecal samples derived from 
three collections of eight subjects without disease (Nam et al. 
2011). Additionally, differences in some of human intestinal 
bacterium were found between healthy controls and patients 
with Crohn’s disease or ulcerative colitis (Gillevet et al. 
2010). Through host inflammation, differences between 
human intestinal bacteria have been commonly shown to 
relate to the pathogenesis of cancer of the colon, stomach, 
breast, gallbladder, esophagus, and pancreas (Sheflin et al. 
2014; Ohtani et al. 2014). In an animal study, the mechanism 
involving inflammation suggests that pathogenic species 
such as Bacteroides fragilis promote colorectal cancer and 
that Fusobacterium species are related to tumor progression 
(Tjalsma et al. 2012; McCoy et al. 2013).
This study has some limitations. The number of subjects 
in the study was small (n = 10), but 40 and 72 fecal samples 
were systematically collected to examine seasonal and daily 
stabilities of human intestinal bacteria, respectively. Bacte-
rial community structure was assessed using the two sets 
of fecal samples from the same subjects. Inter- and intra-
individual variations were examined only for a specific age 
group with equal gender ratio. However, taking into account 
the age and gender distribution, we appropriately recruited 
the subjects. In general, bacterial community structure was 
evaluated bacterial composition (%) because it was diffi-
cult to accurately evaluate “bacterial numbers per fecal dry 
or wet weight.” The data on specific species with >0.1 % 
of the total human gut microbiota are shown, whereas that 
on genera (and species) with <0.1 % were not shown, con-
sidering the measurement limitation for some of them. 
Regarding species classification, in this study, 83 species 
with >0.1 % of the total human gut microbiota were iden-
tified (i.e., 75 and 77, including 69 common, in seasonal 
and daily fecal sample sets, respectively), and a statistically 
significant greater inter-individual variation was observed 
for approximately 65 % of these (supplemental Tables S1 
to S4). Eighteen identified dominant species within >1.0 % 
represented >45 % of the total human gut microbiota.
In conclusion, using the two sets of seasonal and daily 
fecal sample sets, we determined the following indices on 
human gut bacterial community structure: the intra- and 
inter-individual variance, the ratios, CVw (%), CVb (%), 
and the number of days of fecal sample collection required 
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to estimate the compositions within 10 and 20 % of their 
true means. Compared with the intra-individual variance, 
a statistically significant greater inter-individual varia-
tion (“difference between persons”) was found for the 39 
selected dominant genera. Our findings can be helpful to 
interpret human bacterial contribution to the role of human 
gut microbiota in nutritional metabolism, health promotion, 
and prevention/development of diseases in epidemiological 
and clinical studies.
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